Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Erythropoietin/*therapeutic use"'
Autor:
Vladimir Arsenijević, Ana Šijački, Ivan Marjanović, Dušan Micić, Vladimir Nikolić, Aleksandar Veljković, Pavle Popović, Sanja Stanković, Vasilije Jeremić
Publikováno v:
Acta Clinica Croatica, Vol 56., Iss 4., Pp 581-587 (2017)
Polytrauma is a term describing patients with injuries involving multiple body regions that compromises function of the body and/or organ involved. The aim of the study was to evaluate the potential role of erythropoietin in predicting poorer outcome
Externí odkaz:
https://doaj.org/article/0ace7171c6d342a5b33cef4308799f4e
Publikováno v:
Revue medicale suisse, vol. 18, no. 771, pp. 358-363
Renal anemia is a frequently encountered complication in patients suffering from advanced chronic kidney disease. This is mainly due to the decreased secretion of erythropoietin by the diseased kidneys. The current treatment of renal anemia is based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::3d2f76370b4e5bb3715c65dd43a39fa7
https://serval.unil.ch/notice/serval:BIB_C48E5B4F4AB8
https://serval.unil.ch/notice/serval:BIB_C48E5B4F4AB8
Publikováno v:
پزشکی بالینی ابن سینا, Vol 11, Iss 2, Pp 5-9 (2004)
Recombinant human erythropoietin (Epo) is known to accelerate erythropoesis in preterm infants. This study was designed to assess the effect of Epo in treatment of anemia of prematurity . Preterm infants with Hct
Externí odkaz:
https://doaj.org/article/c7240f2233b94cc899e6c304c27ac503
Autor:
Vasilije Jeremić, Aleksandar Veljkovic, Dusan Micic, Pavle Popović, Vladimir Arsenijević, Vladimir M. Nikolic, Sanja Stankovic, Ana Sijacki, Ivan Marjanovic
Publikováno v:
Acta Clinica Croatica, Vol 56, Iss 4, Pp 581-587 (2017)
Acta clinica Croatica
Volume 56.
Issue 4.
Acta clinica Croatica
Volume 56.
Issue 4.
Polytrauma is a term describing patients with injuries involving multiple body regions that compromises function of the body and/or organ involved. The aim of the study was to evaluate the potential role of erythropoietin in predicting poorer outcome